Therapeutic Solutions International (TSOI) reported discovering a new mechanism of action for JadiCell, its investigative stem cell therapy for chronic obstructive pulmonary disease (COPD) and other conditions. Working in animal models, scientists found that JadiCell’s protective effects were dependent on certain immune B-cells and a signaling molecule…
Read more
The National Heart, Lung, and Blood Institute (NHLBI) has awarded $13 million for research focused on the link between the lung endothelium — a thin layer of cells, called endothelial cells, lining the inside of blood vessels in the lungs — and inflammation in lung diseases, including chronic obstructive…
In this podcast series, pulmonary specialist Dr. Noah Greenspan discusses topics related to pulmonary diseases, including COPD.
COPD is a chronic inflammatory disease of the lungs, in which the airways become blocked, causing cough with mucus, wheezing, and shortness of breath.
The causes of COPD are not fully understood. However, long-term exposure to lung irritants is known to damage the lungs and the airways.
Some people may also experience exacerbations, or episodes of sudden disease worsening, that may persist for several days.
Get regular updates to your inbox.
